We also focus on GSK3β and DYRK1A, markers of Alzheimer’s disease, which are also closely associated with pancreatic β-cell dysfunction and type 2 diabetes, and thus may represent common therapeutic targets for both diseases. The gene discussed is DYRK1A; the disease is early-onset autosomal dominant Alzheimer disease.